Literature DB >> 13032386

Ocular findings in haemochromatosis.

J R HUDSON.   

Abstract

Entities:  

Keywords:  EYE; HEMOCHROMATOSIS/manifestations

Mesh：

Year:  1953        PMID： 13032386      PMCID： PMC1324123          DOI： 10.1136/bjo.37.4.242

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  3 in total

1.  Vascular changes in diabetes with particular reference to the retinal vessels; preliminary report.

Authors:  N ASHTON
Journal:  Br J Ophthalmol       Date:  1949-07       Impact factor: 4.638

2.  Superficial perilimbal vessels in the normal and congested eye.

Authors:  J H DOBREE
Journal:  Br J Ophthalmol       Date:  1950-12       Impact factor: 4.638

3.  The significance of conjunctival aneurysms in diabetics.

Authors:  C McCULLOCH; T J PASHBY
Journal:  Br J Ophthalmol       Date:  1950-08       Impact factor: 4.638
  3 in total
  5 in total

1.  A 54-year-old man with bilateral symmetrical circular corneal opacities.

Authors:  Colm McAlinden; Christopher P R Williams
Journal:  Digit J Ophthalmol       Date:  2020-06-21

2.  Deposition of melanin and iron in ocular structures in haemochromatosis.

Authors:  G Davies; I Dymock; J Harry; R Williams
Journal:  Br J Ophthalmol       Date:  1972-04       Impact factor: 4.638

3.  [Protective effects of hemochromatosis against senile and diabetic angiopathies].

Authors:  J Pirart; P Barbier
Journal:  Diabetologia       Date:  1971-08       Impact factor: 10.122

4.  Bull's eye maculopathy associated with hereditary hemochromatosis.

Authors:  Kellyn N Bellsmith; Joshua L Dunaief; Paul Yang; Mark E Pennesi; Ellen Davis; Holly Hofkamp; Brandon J Lujan
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-20

Review 5.  Effects of Excess Iron on the Retina: Insights From Clinical Cases and Animal Models of Iron Disorders.

Authors:  Ali Shahandeh; Bang V Bui; David I Finkelstein; Christine T O Nguyen
Journal:  Front Neurosci       Date:  2022-02-03       Impact factor: 4.677
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.